Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice

Publication date: Available online 27 June 2021Source: Life SciencesAuthor(s): Yuanqiang Zhang, Jing Wen, Dongqing Liu, Zhen Qiu, Qianqian Zhu, Ruiyan Li, Yubin Zhang
Source: Life Sciences - Category: Biology Source Type: research